2,8-DIOXA-5-AZASPIRO[3.5]NONANE HEMIOXALATE, 95.0%, 250mg

1,3-BIS(DICYCLOHEXYLPHOSPHINO)PROPANE, 90%, 250mg

3-Phenyl-cyclohexanol, 98%, 100mg

2-(2-Chloro-4-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 5g

1,4-butanodiol, mínimo 99,0 %, para síntesis, 2,5 l, envase de vidrio

Rubidium sulfate, 99.5% metals basis, 100g

trans-2,3-Difluorocinnamic acid, 97.0%, 5g

(5S,8S,11S,12R)-11-((S)-sec-Butyl)-1-(9H-fluoren-9-yl)-5,8-diisopropyl-12-methoxy-4,10-dimethyl-3,6,9-trioxo-2-oxa-4,7,10-triazatetradecan-14-oic acid, 98%, 100mg

N-(9-((2R,3R,4R,5R)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide, 98%, 10g

4,4'-(5'-(4-(Pyridin-4-yl)phenyl)-[1,1':3',1''-terphenyl]-4,4''-diyl)dipyridine, 97%, 500mg

7-Aminoheptanoic acid ethyl ester hydrochloride, 95.0%, 100g

2-((4-Methylpyrimidin-2-yl)thio)acetic acid, 97%, 5g

(2S,4S)-1-(tert-Butoxycarbonyl)-4-fluoro-2-pyrrolidinecarboxylic Acid>97.0%(T)1g